Akèy › Sindrom Cushing
Etid klinik pou Sindrom Cushing ap rekrite nan Etazini
12 etid pou Sindrom Cushing ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Oct 2, 2026 · NCT02019706Evaluation of Adults With Endocrine and Metabolic-Related Conditions
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT02830308Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07138274Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism
Ap rekriteFaz 2
Laj 18 a 120 · Tout sèks · Mizajou Sep 23, 2026 · NCT06246357Recovery From Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS)
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT04543253A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement
Ap rekriteEtid obsèvasyon
Laj 18 a 75 · Tout sèks · Mizajou Sep 9, 2026 · NCT06430528Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07296484Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome
Ap rekriteFaz 2Volontè an sante akeyi
Laj 18 a 70 · Tout sèks · Mizajou Aug 31, 2026 · NCT06635629IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 27, 2026 · NCT07361874Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
Ap rekriteFaz 2
Laj 2 a 17 · Tout sèks · Mizajou Mar 27, 2026 · NCT03708900Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Feb 11, 2026 · NCT07104812Collecting Information About Treatment Results for Patients With Cushing's Syndrome
Ap rekriteEtid obsèvasyon
Laj 14 ak plis · Tout sèks · Mizajou Oct 23, 2025 · NCT03364803Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.